http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100416655-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0626
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01S3-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067
filingDate 2001-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100416655-B1
titleOfInvention Photodymaminc therapy apparatus using soid state laser
abstract The present invention relates to a PDT photodynamic therapy device using a solid state laser to treat malignant tumors and a treatment method using the therapy device, wherein the photodynamic therapy device is a power supply device for supplying power required to drive a pump, such as a laser oscillator. Wow; A pump including a pulse flash lamp for generating light and an active element for generating a laser of a predetermined wavelength using light from the flash lamp, the pump for generating a laser of a predetermined wavelength necessary for the treatment of malignant tumors; A first light resonance reflector for reflecting and amplifying the laser generated by the pump, and a fifth rotation reflector for reflecting the laser light reflected from the first light resonance reflector to the crystallite of barium nitrate (Ba (NO 3) 2); Wow; A barium nitrate crystal which receives the laser reflected through the fifth rotating reflector, converts the wavelength into a predetermined wavelength, and sends the laser to a lithium fluoride (LiF) crystal; A lithium fluoride crystal which receives a laser beam passing through the barium nitrate crystal side and changes the wavelength to a predetermined wavelength; KTP (potassium titanium phosphate) crystals, which convert the laser beam passing through the lithium fluoride crystals into wavelengths necessary for the treatment of malignant tumors; Third and fourth reflection rotating mirrors which give only necessary laser light among lasers having a predetermined wavelength passing through the KTP crystals; And a condenser lens for condensing laser light from the third and fourth reflective rotating mirrors and irradiating the affected area directly through an optical fiber or using an endoscope. After administering HPD, a blood product that accumulates more in malignant tumor tissue than in normal tissue, to the tumor tissue lesion of a patient, a laser having an energy level that is not harmful to the human body generated in the PDT photodynamic therapy device configured as described above is used. HPD is accumulated in the tumor tissue and the reactive oxygen is generated by HPD chemical reaction to necrosis the lipid of tumor tissue cells to necrosis tumor tissue.
priorityDate 2001-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990049482-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162077215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412483216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411303245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID224478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450553823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15769376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42608478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454458487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449824900

Total number of triples: 37.